# SITE (SITC): BriaCell and BriaPro Present, an 81.3% Drop

> Source: IndicatorStack, https://indicatorstack.com/catalysts/sitc-2026-11-06-release. Updated Nov 19, 2026, 4:41 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

SITE Centers (SITC) announced BriaCell and BriaPro Present at 9:00 AM ET on Friday, November 6, and the stock went from Thursday’s $3.57 close to as low as $0.5900. It finished the session −81.3% at $0.6680 on 4.3 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 3:59 AM ET. NYSE: SITC, REIT - Retail. All times ET.

## The numbers

- −81.3% Friday’s close ($3.57 to $0.6680, low $0.5900)
- 4.3× its 20-day average volume (15M shares on the day)
- 9:00 AM the catalyst crossed, ET (Friday, before the open)
- 52.3M float, shares (29% of the float traded on Friday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Thu close | $3.57 | Bearish, strong | Leaning down |
| Into the open | Fri 9:30 AM | $0.6199 | Bearish, weakening | Tailwind down |
| 30 minutes in | Fri 10:00 AM | $0.7098 | Neutral | Tailwind down |
| At the close | Fri 4:00 PM | $0.6684 | Bearish, weakening | Tailwind down |
| Monday’s close | Mon 4:00 PM | $0.6850 | Bullish, weakening | Higher timeframes still down |
| Tuesday’s close | Tue 4:00 PM | $0.6879 | Bearish, strong | 15m and 1h down |
| Wednesday’s close | Wed 4:00 PM | $0.6700 | Neutral | 15m and 1h down |

## Timeline

### Friday, November 6

- 4:00 AM: Premarket high $0.8800 (−75.4% from the prior close)
- 9:00 AM: BriaCell and BriaPro Present (Press release, GlobeNewsWire)
- 9:00 AM: Atebimetinib Combinations with Anti-PD1 Cured 50% of mice (Press release, GlobeNewsWire)
- 9:00 AM: IMUNON Presents new Translational data at SITC 2026 (Press release, GlobeNewsWire)
- 9:00 AM: Candel Therapeutics Presents SITC 2026 (Press release, GlobeNewsWire)
- 9:05 AM: Phio Pharmaceuticals announces Invitation for Oral Presentation (Press release, Newsfile Corp)
- 9:05 AM: Obsidian Therapeutics to Present updated Amsoki-cel Efficacy and (Press release, Business Wire)
- 9:30 AM: Session low $0.5900
- 9:30 AM: Opened at $0.6100 (−82.9% from Thursday’s $3.57 close)
- 9:45 AM: Session high $0.7332
- 9:45 AM: 5-minute stack bias went neutral (at $0.7111, its inputs no longer agreeing)
- 9:45 AM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $0.7111)
- 9:48 AM: MiNK Therapeutics new data Highlights its Off-the-Shelf (Press release, GlobeNewsWire)
- 11:15 AM: 5-minute stack bias turned bearish (at $0.6722)
- 11:55 AM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $0.6742)
- 12:00 PM: Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide zapixetar (Press release, GlobeNewsWire)
- 4:00 PM: Closed at $0.6680, −81.3% on the day (15M shares, 4.3× its 20-day average)

### Monday, November 9

- 7:00 AM: GT Biopharma oral presentation at the SITC 2026 annual meeting (Press release, GlobeNewsWire)
- 8:30 AM: Werewolf Therapeutics' clinical data for WTX-124 and WTX-330 presented (Press release, GlobeNewsWire)
- 9:25 AM: 5-minute stack bias turned bearish (at $0.6654)
- 9:30 AM: Session low $0.6324
- 9:30 AM: Opened at $0.6600 (−1.2% from Friday’s $0.6680 close)
- 10:35 AM: Trigger marked a long at $0.6565 (Hypothetical, default settings: reached $0.6705 at 11:30 AM for +1.4R (volume flow turned down))
- 10:45 AM: 5-minute stack bias went neutral (at $0.6576, its inputs no longer agreeing)
- 11:15 AM: 5-minute stack bias turned bullish (at $0.6701)
- 3:10 PM: Session high $0.7058
- 4:00 PM: Closed at $0.6733, +0.8% on the day (5.4M shares, 1.3× its 20-day average)

### Tuesday, November 10

- 8:30 AM: 5-minute stack bias turned bearish (at $0.6800)
- 9:30 AM: Session low $0.6614
- 9:30 AM: Opened at $0.6700 (−0.5% from Monday’s $0.6733 close)
- 10:05 AM: 5-minute stack bias went neutral (at $0.6837, its inputs no longer agreeing)
- 10:40 AM: Session high $0.7155
- 10:45 AM: 5-minute stack bias turned bullish (at $0.7054)
- 1:50 PM: 5-minute stack bias went neutral (at $0.6983, its inputs no longer agreeing)
- 3:05 PM: 5-minute stack bias turned bearish (at $0.6905)
- 4:00 PM: Closed at $0.6800, +1.0% on the day (2M shares, 0.4× its 20-day average)

### Wednesday, November 11

- 9:30 AM: Opened at $0.6871 (+1.0% from Tuesday’s $0.6800 close)
- 10:15 AM: Session low $0.6504
- 11:50 AM: 5-minute stack bias went neutral (at $0.6814, its inputs no longer agreeing)
- 12:05 PM: Session high $0.6944
- 12:05 PM: 5-minute stack bias turned bullish (at $0.6904)
- 1:45 PM: 5-minute stack bias went neutral (at $0.6816, its inputs no longer agreeing)
- 2:00 PM: 5-minute stack bias turned bearish (at $0.6770)
- 3:20 PM: 5-minute stack bias went neutral (at $0.6828, its inputs no longer agreeing)
- 4:00 PM: Closed at $0.6775, −0.4% on the day (1.4M shares, 0.3× its 20-day average)

## Before the catalyst (Thursday, November 5)

SITE Centers closed Thursday at $3.57. The 5-minute stack bias was bearish (strong), since 2:25 PM: under VWAP 3.62 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “Leaning down” (15m ↓ 1h ↓ 2h ↓ 4h ↗ D ↗). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way. Its Next row read “Selling drying up at 3.58, squeeze risk rising”.

Over the year before, it had traded between $2.80 and $7.49. The week before, on Tuesday, November 3, the company had announced BriaCell and BriaPro to Present preclinical Anti-Cancer Activity and at 9:00 AM ET.

## The release and an 81.3% drop (Friday, November 6)

The release crossed at 9:00 AM ET. Premarket trading carried it to $0.8800 by 4:00 AM, −75% from the prior close, on 65K shares before the bell. It opened at $0.6100, −82.9%, and the regular session ranged from $0.5900 to $0.7332 before closing at $0.6680. It did this on a day SPY rose 0.3% and XLRE, the reit - retail ETF, fell 0.7%.

Into the open the stack read it as bearish (weakening) with 5 of 5 higher timeframes down, and Undertow read “sellers in control”. Thirty minutes in, the picture had changed: price held above VWAP at $0.6701 and the Next row read “Range 0.5937 to 0.7329, no edge in the middle”. By the close the 5-minute bias was bearish from 11:15 AM, while Compass still read “Tailwind down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Monday, November 9)

It opened at $0.6600 (−1.2%) and traded from $0.6324 to $0.7058, closing at $0.6733, +0.8% on 5.4M shares, still 1.3 times its 20-day average. The 5-minute stack bias was bullish (weakening), since 11:15 AM: over VWAP 0.6779, momentum up and net buying. Compass read “Higher timeframes still down” (15m ↗ 1h ↓ 2h ↓ 4h ↘ D ↘). Undertow: volume surge, sellers hitting the bid. Tripwire: Longs: Avoid, support looks fake, heavy tape on it.

## The session after (Tuesday, November 10)

It opened at $0.6700 (−0.5%) and traded from $0.6614 to $0.7155, closing at $0.6800, +1.0% on 2M shares, still 0.4 times its 20-day average. The 5-minute stack bias was bearish (strong), since 3:05 PM: under VWAP 0.6972 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “15m and 1h down” (15m ↘ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.

## The session after (Wednesday, November 11)

It opened at $0.6871 (+1.0%) and traded from $0.6504 to $0.6944, closing at $0.6775, −0.4% on 1.4M shares, still 0.3 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h down” (15m ↓ 1h ↓ 2h ↓ 4h ↓ D ↓). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Avoid, sitting right on support at 0.6696.

After hours it last traded at $0.6510, with Undertow reading “sellers in control”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 52.5M | as reported to the SEC |
| Float | 52.3M | 100% of shares outstanding |
| Reverse splits on record | 2 | 1-for-4 reverse split, August 19, 2024; 1-for-2 reverse split, May 21, 2018 |
| Last insider sale | November 9, 2026 | 30K shares at $0.6757 |

## Sources

- Mon Nov 9, 8:30 AM ET, Press release: Werewolf Therapeutics' clinical data for WTX-124 and WTX-330 presented (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/09/3398415/0/en/werewolf-therapeutics-clinical-data-for-wtx-124-and-wtx-330-presented-at-the-society-for-immunotherapy-of-cancer-s-sitc-2026-annual-meeting.html
- Mon Nov 9, 7:00 AM ET, Press release: GT Biopharma oral presentation at the SITC 2026 annual meeting (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/09/3398235/0/en/gt-biopharma-oral-presentation-at-the-sitc-2026-annual-meeting.html
- Fri Nov 6, 12:00 PM ET, Press release: Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide zapixetar (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397790/0/en/perspective-therapeutics-presents-promising-212pb-lapemelanotide-zapixetar-vmt01-monotherapy-data-from-a-phase-1-2a-study-in-heavily-pretreated-advanced-melanoma-patients-at-sitc-2.html
- Fri Nov 6, 9:48 AM ET, Press release: MiNK Therapeutics new data Highlights its Off-the-Shelf (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397617/0/en/mink-therapeutics-new-data-highlights-its-off-the-shelf-inkt-cell-therapy-targets-two-key-mechanisms-of-tumor-resistance-presented-at-the-society-of-immunotherapy-of-cancer-sitc-20.html
- Fri Nov 6, 9:05 AM ET, Press release: Phio Pharmaceuticals announces Invitation for Oral Presentation (Newsfile Corp) https://www.newsfilecorp.com/release/322719/Phio-Pharmaceuticals-Announces-Invitation-for-Oral-Presentation-at-41st-Annual-SITC-Meeting-Society-for-Immunotherapy-of-Cancer
- Fri Nov 6, 9:05 AM ET, Press release: Obsidian Therapeutics to Present updated Amsoki-cel Efficacy and (Business Wire) https://www.businesswire.com/news/home/20261106751284/en/Obsidian-Therapeutics-to-Present-Updated-Amsoki-cel-Efficacy-and-Pooled-Safety-Data-in-Advanced-Melanoma-at-SITC-2026-Annual-Meeting/
- Fri Nov 6, 9:00 AM ET, Press release: BriaCell and BriaPro Present (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397526/0/en/briacell-and-briapro-present-positive-preclinical-immunotherapy-data-across-four-posters-at-sitc-2026.html
- Fri Nov 6, 9:00 AM ET, Press release: Atebimetinib Combinations with Anti-PD1 Cured 50% of mice (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397545/0/en/atebimetinib-combinations-with-anti-pd1-cured-50-of-mice-in-a-ras-mutant-colorectal-cancer-model-and-nearly-doubled-survival-in-a-ras-mutant-lung-cancer-model-new-data-presented-at.html
- Fri Nov 6, 9:00 AM ET, Press release: IMUNON Presents new Translational data at SITC 2026 (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397525/0/en/imunon-presents-new-translational-data-at-sitc-2026-demonstrating-how-imnn-001-activates-and-sustains-anti-tumor-t-cell-immunity-in-advanced-ovarian-cancer.html
- Fri Nov 6, 9:00 AM ET, Press release: Candel Therapeutics Presents SITC 2026 (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/06/3397542/0/en/candel-therapeutics-presents-sitc-2026-data-highlighting-systemic-immune-activation-and-survival-outcomes-across-clinical-stage-portfolio.html
- Mon Nov 2, 4:15 PM ET, SEC filing: Quarterly report (Form 10-Q) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/894315/000119312526443679/sitc-20260930.htm
- Mon Nov 2, 4:10 PM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/894315/000119312526443658/sitc-20261102.htm
- Fri Oct 30, 1:56 PM ET, SEC filing: Ownership stake over 5% (Schedule 13G) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/894315/000210012126001122/xslSCHEDULE_13G_X02/primary_doc.xml

## Questions

### Why did SITC stock go down on November 6?

SITE Centers (SITC) announced BriaCell and BriaPro Present at 9:00 AM ET on Friday, November 6, and the stock went from Thursday’s $3.57 close to as low as $0.5900. It finished the session −81.3% at $0.6680 on 4.3 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did SITE Centers announce on November 6, 2026?

SITE Centers (SITC) announced BriaCell and BriaPro Present at 9:00 AM ET on Friday, November 6.

### How did SITC stock trade on November 6?

SITC opened at $0.6100, −82.9% from the prior close of $3.57, traded between $0.5900 and $0.7332 in the regular session and closed at $0.6680, −81.3%, on 15M shares.

### How did LiveChart’s stack read SITC at the close on November 6?

At the 4:00 PM ET close the 5-minute stack bias on SITC was bearish (weakening), Compass read “Tailwind down” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on SITC now?

The read on this page is fixed at each moment it describes. LiveChart reads SITC on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/SITC. SITC catalyst history: https://indicatorstack.com/catalysts/stock/SITC

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
